Law Office of Brodsky & Smith, LLC Announces Investigation of
DUSA Pharmaceuticals, Inc. and JDA Software Group, Inc.
BALA CYNWYD, Pa., Nov. 10, 2012 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of DUSA
Pharmaceuticals, Inc. ("DUSA" or the "Company") (Nasdaq- DUSA-News)
relating to the proposed acquisition by Sun Pharmaceutical
Industries Ltd. ("Sun").
Under the terms of the transaction, DUSA shareholders will
receive only $8.00 in cash for each
share of DUSA stock they own. The transaction may undervalue the
Company and will not result in any substantial gain for many DUSA
shareholders as DUSA stock traded at $7.00 on October 16,
2012. In addition, an analyst has set a $9.50 per share price target for DUSA.
If you own shares of DUSA stock and have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your
questions. You may contact Jason L.
Brodsky, Esquire or Evan J. Smith,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by
e-mail at investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/501-dusa-dusa-pharmaceuticals-inc.html, by
calling toll free 877-LEGAL-90.
Investigation of JDA Software Group, Inc.
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
JDA Software Group, Inc. ("JDA Software" or the "Company") (Nasdaq-
JDAS-News) relating to the proposed acquisition by RedPrairie
Corporation. ("RedPrairie"). Under the terms of the transaction,
JDA Software shareholders will receive only $45.00 in cash for each share on JDA Software
common stock they own. The investigation concerns possible breaches
of fiduciary duty and other violations of state law by the Board of
Directors of JDA Software for not acting in the Company's
shareholders' best interests in connection with the sale process to
RedPrairie.
If you own shares of JDA Software stock and have any questions,
you may e-mail or call the law office of Brodsky & Smith, LLC
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Jason L.
Brodsky, Esquire or Evan J. Smith,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by
e-mail at investorrelations@brodsky-smith.com visiting
http://brodsky-smith.com/496-jdas-jda-software-group-inc.html, by
calling toll free 877-LEGAL-90.
Attorney Advertising. Past results do not guarantee a similar
outcome.
SOURCE Brodsky & Smith, LLC
